Rock Springs Capital Management LP Protara Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.38 - $9.3 $4.42 Million - $6.45 Million	-693,542 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.68 - $16.99 $31,248 - $61,163	3,600 Added 0.52%	693,542 $6.76 Million
Q1 2021 May 17, 2021	BUY	$13.75 - $23.86 $642,702 - $1.12 Million	46,742 Added 7.27%	689,942 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$16.97 - $25.34 $7,161 - $10,693	-422 Reduced 0.07%	643,200 $15.6 Million
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $10.8 Million - $20.5 Million	643,622 New	643,622 $10.8 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $60.7M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.